Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial (Q38442153)
Jump to navigation
Jump to search
scientific article published on December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial |
scientific article published on December 2013 |
Statements
1 reference
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial (English)
1 reference
Deepak L Bhatt
1 reference
Alexandre Abizaid
1 reference
Andrea S Abizaid
1 reference
Martin B Leon
1 reference
Fausto Feres
1 reference
Ricardo A Costa
1 reference
J Antônio Marin-Neto
1 reference
Roberto V Botelho
1 reference
Spencer B King
1 reference
Manuela Negoita
1 reference
Minglei Liu
1 reference
J Eduardo T de Paula
1 reference
José A Mangione
1 reference
George X Meireles
1 reference
Hélio J Castello
1 reference
Eduardo L Nicolela
1 reference
Marco A Perin
1 reference
Fernando S Devito
1 reference
André Labrunie
1 reference
Décio Salvadori
1 reference
Marcos Gusmão
1 reference
Rodolfo Staico
1 reference
J Ribamar Costa
1 reference
Juliana P de Castro
1 reference
OPTIMIZE Trial Investigators
1 reference
1 December 2013
1 reference
1 reference
Identifiers
1 reference